Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

178
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
178
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

407
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
407
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

552
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

331
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
331
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

549
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
549
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

200
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
200

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Embryonic arrest at midgestation and disruption of Notch signaling produced by the absence of both epsin 1 and epsin 2 in mice.

Proceedings of the National Academy of Sciences of the United States of America·2009
Same author

Two novel SNPs in coding region of the caprine Fat-inducing transcript gene and their association with growth traits.

Molecular biology reports·2009
Same author

Reprogramming human fibroblasts using HIV-1 TAT recombinant proteins OCT4, SOX2, KLF4 and c-MYC.

Molecular biology reports·2009
Same author

Bioinformatics and microarray analysis of microRNA expression profiles of murine embryonic stem cells, neural stem cells induced from ESCs and isolated from E8.5 mouse neural tube.

Neurological research·2009
Same author

Attenuation of lipopolysaccharide-mediated left ventricular dysfunction by glutamine preconditioning.

The Journal of surgical research·2009
Same author

Differential regulation of Apak by various DNA damage signals.

Molecular and cellular biochemistry·2009

相关实验视频

Updated: Jan 11, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

7.3K

预测慢性病中功能衰退的整体机器学习:开发和外部验证

Hong Chen1, Yuping Huang1, Lizhen Chen2

  • 1Department of Nephrology, the 95th Hospital of Putian in China RongTong Medical Health Corporation, Putian, China.

Frontiers in medicine
|November 12, 2025
PubMed
概括

一个新的机器学习模型准确地预测慢性病 (CKD) 的进展,优于传统方法. 这种工具可以为个性化CKD管理提供早期风险分层.

关键词:
慢性病的进展和进展临床决策支持 临床决策支持机器学习是机器学习.精密脏病学 精密脏病学风险预测建模风险预测建模

更多相关视频

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

相关实验视频

Last Updated: Jan 11, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

7.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學.
  • 人工智能在医学中的应用
  • 生物统计学 生物统计学

背景情况:

  • 慢性病 (CKD) 是一个全球性的健康问题,具有显著的发病率和死亡率.
  • 目前对CKD进展的预测模型往往缺乏准确性和概括性.
  • 及时干预对于管理慢性病患者功能下降至关重要.

研究的目的:

  • 开发和验证一个整体机器学习模型,用于更好地预测CKD患者功能下降的情况.
  • 为了能够为CKD管理提供早期和个性化的干预措施.
  • 提高CKD进展预测的准确性和通用性.

主要方法:

  • 使用随机森林,XGBoost和LightGBM算法开发了一个整体机器学习模型.
  • 该模型是根据1200名CKD患者的数据进行训练和验证的,包括临床,人口和实验室数据.
  • 在三个医疗中心使用AUC,校准指标和外部验证来评估性能.

主要成果:

  • 整体模型实现了0.89的AUC,超过了传统的Cox模型 (AUC:0.82) 和标准ML方法 (AUC:0.85).
  • 关键预测因素包括估计的膜过率 (eGFR),年龄和尿蛋白-肌素比率.
  • 该模型表现出了出色的校准,并减少了60.6%的计算资源使用.

结论:

  • 开发的机器学习模型在预测CKD进展方面取得了重大进展.
  • 它为CKD患者早期风险分层提供了一个可靠和可通用的工具.
  • 整合到临床工作流程中可以促进主动的,数据驱动的干预措施,以改善CKD管理.